Literature DB >> 8932422

In vitro effects of high-energy pulsed ultrasound on human squamous cell carcinoma cells.

H Iro1, T Feigl, J Zenk, F Waldfahrer.   

Abstract

Human squamous cell carcinoma cells cloned from the hypopharynx (FaDu) and oral cavity (SCC-4) were exposed to high-energy pulsed ultrasound (HEPUS) in vitro to evaluate the effects of various physical parameters on cell viability. Such included the number of pulses, voltage applied, pulse repetition rate and cell density. The experimental piezoelectric ultrasound transducer used in the experiments generated pulses with a high negative pressure amplitude. By varying the repetition frequency from 0.6 to 8 Hz, cell viability was found to be least when pulse repetition was approximately 1 Hz. An increase in transducer voltage resulted in a linear decrease in cell viability. The cell survival rate dropped exponentially as a function of the number of pulses applied, reaching 4.2% after 2000 pulses. The cell survival rate exhibited no significant dependence on cell density when cells ranged from 1 to 3.5 x 10(6) cells ml-1. Data obtained with trypan blue dye exclusion were confirmed by measurements of intracellular lactate dehydrogenase released into an extracellular fluid supernatant. By applying HEPUS to tumor cells, almost complete destruction of the cells could be achieved in vitro. The degree of cell destruction achieved depended significantly on the number of pulses administered, the pulse repetition rate and the transducer voltage applied.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8932422     DOI: 10.1007/bf00176695

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  11 in total

1.  What makes a shock wave efficient in lithotripsy?

Authors:  B Granz; G Köhler
Journal:  J Stone Dis       Date:  1992-04

Review 2.  Bioeffects of extracorporeal shock-wave lithotripsy. Strategy for research and treatment.

Authors:  J E Lingeman; J A McAteer; S A Kempson; A P Evan
Journal:  Urol Clin North Am       Date:  1988-08       Impact factor: 2.241

3.  Histopathology of shock wave treated tumor cell suspensions and multicell tumor spheroids.

Authors:  T Bräuner; F Brümmer; D F Hülsĕr
Journal:  Ultrasound Med Biol       Date:  1989       Impact factor: 2.998

4.  Effect of shock waves on suspended and immobilized L1210 cells.

Authors:  F Brümmer; J Brenner; T Bräuner; D F Hülser
Journal:  Ultrasound Med Biol       Date:  1989       Impact factor: 2.998

5.  Tissue reactions under piezoelectric shockwave application for the fragmentation of biliary calculi.

Authors:  C Ell; W Kerzel; N Heyder; W Rödl; H Langer; U Mischke; J Giedl; W Domschke
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

6.  Effect of electrohydraulic and extracorporeal shock waves on gastrointestinal cancer cells and their response to cytotoxic agents.

Authors:  A Warlters; D L Morris; A Cameron-Strange; W Lynch
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

7.  The in vitro effect of electromagnetically generated shock waves (Lithostar) on the Dunning R3327 PAT-2 rat prostatic cancer cell-line. A potentiating effect on the in vitro cytotoxicity of vinblastin.

Authors:  G O Oosterhof; G A Smits; J E de Ruyter; R J van Moorselaar; J A Schalken; F M Debruyne
Journal:  Urol Res       Date:  1989

8.  Cytotoxic effects of high energy shock waves in different in vitro models: influence of the experimental set-up.

Authors:  G A Smits; G O Oosterhof; A E de Ruyter; J A Schalken; F M Debruyne
Journal:  J Urol       Date:  1991-01       Impact factor: 7.450

9.  In vitro cytotoxic activity of lithotripter shock waves combined with adriamycin or with cisplatin on L1210 mouse leukemia cells.

Authors:  A Wilmer; S Gambihler; M Delius; W Brendel
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

10.  High energy shock waves suppress tumor growth in vitro and in vivo.

Authors:  P Russo; R A Stephenson; C Mies; R Huryk; W D Heston; M R Melamed; W R Fair
Journal:  J Urol       Date:  1986-03       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.